Clinical Trials in Minneapolis

Showing 2381-2400 of 6,957 trials

International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry

NCT01464606

Pleuropulmonary Blastoma (PPB) is very rare and there is no established "standard" or "best" therapy. For many years, children with PPB around the world have been treated according to decisions made case-by-case in many different hospitals by many different physicians. No treatment has been tested in a large group of PPB patients. The goal is to treat many children with one treatment program and to learn the results of the treatment.

Pleuropulmonary Blastoma

Children's Hospitals and Clinics of Minnesota156 participantsStarted Dec 2009

Minneapolis, Minnesota, United States

RECRUITING< 1 mile

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

NCT04509050

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children with cystic fibrosis (CF).

Cystic Fibrosis

Sonya Heltshe210 participantsStarted Nov 2020

Birmingham, Alabama, United States • Palo Alto, California, United States • Aurora, Colorado, United States +32 more locations

International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

Find Trials by Condition in Minneapolis

Training for Health Professionals In Tanzania

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

Study of OMNI System in OAG (GEMINI)

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

A Study of ZN-c5 in Subjects With Breast Cancer

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Comparing Two Models of Well-Child Care for Black Families

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer